77 related articles for article (PubMed ID: 15580397)
1. Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
Raymond J; Kalach N; Bergeret M; Benhamou PH; Barbet JP; Gendrel D; Dupont C
Antimicrob Agents Chemother; 1998 Jun; 42(6):1334-5. PubMed ID: 9624470
[TBL] [Abstract][Full Text] [Related]
2. Replacement of clarithromycin with azithromycin in triple therapy regimens for the eradication of Helicobacter pylori: A randomized clinical trial.
Khoshnood A; Hakimi P; Salman-Roghani H; Reza Mirjalili M
J Med Life; 2014 Jun; 7(2):254-9. PubMed ID: 25408735
[TBL] [Abstract][Full Text] [Related]
3. Rescue Therapy for Helicobacter pylori Infection 2012.
Gisbert JP
Gastroenterol Res Pract; 2012; 2012():974594. PubMed ID: 22536225
[TBL] [Abstract][Full Text] [Related]
4. Second-line rescue therapy of helicobacter pylori infection.
Gisbert JP
Therap Adv Gastroenterol; 2009 Nov; 2(6):331-56. PubMed ID: 21180581
[TBL] [Abstract][Full Text] [Related]
5. Virulence factor genotypes of Helicobacter pylori affect cure rates of eradication therapy.
Sugimoto M; Yamaoka Y
Arch Immunol Ther Exp (Warsz); 2009; 57(1):45-56. PubMed ID: 19219527
[TBL] [Abstract][Full Text] [Related]
6. "Rescue" regimens after Helicobacter pylori treatment failure.
Gisbert JP
World J Gastroenterol; 2008 Sep; 14(35):5385-402. PubMed ID: 18803350
[TBL] [Abstract][Full Text] [Related]
7. Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy.
Shirai N; Sugimoto M; Kodaira C; Nishino M; Ikuma M; Kajimura M; Ohashi K; Ishizaki T; Hishida A; Furuta T
Eur J Clin Pharmacol; 2007 Aug; 63(8):743-9. PubMed ID: 17565490
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Mousavi S; Toussy J; Yaghmaie S; Zahmatkesh M
World J Gastroenterol; 2006 Jul; 12(28):4553-6. PubMed ID: 16874871
[TBL] [Abstract][Full Text] [Related]
9. Update on Therapeutic Options for Helicobacter pylori-related Diseases.
Mégraud F
Curr Infect Dis Rep; 2005 Mar; 7(2):115-120. PubMed ID: 15727738
[TBL] [Abstract][Full Text] [Related]
10. [Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Nagahara A; Miyazaki A; Miwa H; Sato N
Nihon Rinsho; 2002 Feb; 60 Suppl 2():435-8. PubMed ID: 11979822
[No Abstract] [Full Text] [Related]
11. [First line therapy for Helicobacter pylori eradication in France].
Dupas JL
Gastroenterol Clin Biol; 2003 Mar; 27(3 Pt 2):467-72. PubMed ID: 12700504
[TBL] [Abstract][Full Text] [Related]
12. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Nagahara A; Miwa H; Kawabe M; Kurosawa A; Asaoka D; Hojo M; Iijima K; Terai T; Ohkusa T; Miyazaki A; Sato N
J Gastroenterol; 2004 Nov; 39(11):1051-5. PubMed ID: 15580397
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Matsuhisa T; Kawai T; Masaoka T; Suzuki H; Ito M; Kawamura Y; Tokunaga K; Suzuki M; Mine T; Takahashi S; Sakaki N
Helicobacter; 2006 Jun; 11(3):152-8. PubMed ID: 16684262
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Shimoyama T; Fukuda S; Mikami T; Fukushi M; Munakata A
J Gastroenterol; 2004 Oct; 39(10):927-30. PubMed ID: 15549444
[TBL] [Abstract][Full Text] [Related]
15. Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Murakami K; Okimoto T; Kodama M; Sato R; Miyajima H; Ono M; Inoue K; Watanabe K; Otsu S; Fujioka T
Helicobacter; 2006 Oct; 11(5):436-40. PubMed ID: 16961805
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
